A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.

Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.

Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.

A team of researchers used genome editing to inactivate the PCSK9 protein in the livers of rhesus macaque monkeys, resulting in 30 to 60 percent reductions in LDL cholesterol and even more significant drops in PCSK9 levels.

A new study published in the European Heart Journal suggests a particular quality of LDL cholesterol—not just the concentration of it—influences a patient’s risk of cardiovascular disease.

The more a person smokes, the greater the risk of developing a heart rhythm disorder, according to a new study published July 11 in the European Journal of Preventive Cardiology.

The FDA has approved the third generation of the MitraClip, which treats mitral regurgitation without open-heart surgery, device manufacturer Abbott announced July 12.

For decades, cardiologists have insisted patients take it easy after a heart attack—but younger physicians believe in encouraging patients be active, and even run, because exercise decreases the chances of a subsequent cardiac event.